Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma.
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D002478:Cells, Cultured; D004970:Estrone / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011980:Receptors, Progesterone / Q000378:metabolism; D013629:Tamoxifen / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology
D011980:Receptors, Progesterone; D013629:Tamoxifen; D004970:Estrone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone